These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 21300764)

  • 21. The host STING pathway at the interface of cancer and immunity.
    Corrales L; McWhirter SM; Dubensky TW; Gajewski TF
    J Clin Invest; 2016 Jul; 126(7):2404-11. PubMed ID: 27367184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.
    Steitz J; Brück J; Lenz J; Knop J; Tüting T
    Cancer Res; 2001 Dec; 61(24):8643-6. PubMed ID: 11751377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.
    Lamberti MJ; Mentucci FM; Roselli E; Araya P; Rivarola VA; Rumie Vittar NB; Maccioni M
    Front Immunol; 2019; 10():2614. PubMed ID: 31781113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
    Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.
    Pan J; Zhang M; Wang J; Wang Q; Xia D; Sun W; Zhang L; Yu H; Cao X
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):468-78. PubMed ID: 15711825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmacytoid dendritic cells mature independently of MyD88 and IFN-αβR in response to Listeria and stimulate CD8 T cells.
    Tam MA; Wenzel UA; Wick MJ
    Immunol Lett; 2011 Aug; 138(2):104-12. PubMed ID: 21453725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature.
    Spaapen RM; Leung MY; Fuertes MB; Kline JP; Zhang L; Zheng Y; Fu YX; Luo X; Cohen KS; Gajewski TF
    J Immunol; 2014 Oct; 193(8):4254-60. PubMed ID: 25217157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting the CD8
    Chen HY; Xu L; Li LF; Liu XX; Gao JX; Bai YR
    Sci Rep; 2018 Aug; 8(1):11934. PubMed ID: 30093664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
    Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
    Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
    Wu J; Meng Z; Jiang M; Zhang E; Trippler M; Broering R; Bucchi A; Krux F; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Immunology; 2010 Mar; 129(3):363-74. PubMed ID: 19922426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming.
    Le Bon A; Durand V; Kamphuis E; Thompson C; Bulfone-Paus S; Rossmann C; Kalinke U; Tough DF
    J Immunol; 2006 Apr; 176(8):4682-9. PubMed ID: 16585561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
    Diamond JM; Vanpouille-Box C; Spada S; Rudqvist NP; Chapman JR; Ueberheide BM; Pilones KA; Sarfraz Y; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Aug; 6(8):910-920. PubMed ID: 29907693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
    Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
    Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses.
    Udayakumar TS; Betancourt DM; Ahmad A; Tao W; Totiger TM; Patel M; Marples B; Barber G; Pollack A
    Mol Cancer Res; 2020 Aug; 18(8):1232-1243. PubMed ID: 32366674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1
    Tsuchiya N; Zhang R; Iwama T; Ueda N; Liu T; Tatsumi M; Sasaki Y; Shimoda R; Osako Y; Sawada Y; Kubo Y; Miyashita A; Fukushima S; Cheng Z; Nakaki R; Takubo K; Okada S; Kaneko S; Ihn H; Kaisho T; Nishimura Y; Senju S; Endo I; Nakatsura T; Uemura Y
    Cell Rep; 2019 Oct; 29(1):162-175.e9. PubMed ID: 31577946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I interferon as a stimulus for cross-priming.
    Le Bon A; Tough DF
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):33-40. PubMed ID: 18068417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.